IP Library › Assignment 045764/0322
Patent Assignment
Reel/Frame 045764/0322

Assignment of Assignor's Interest

Recorded: 2018-05-10 Pages: 7
Assignor
OHR PHARMACEUTICAL, INC.
Executed: 2018-04-18
Assignee
ENTERIN, INC.
274 LINDEN LANE, MERION, PENNSYLVANIA, 19066
Covered Properties (3)
Polymorphic and amorphous salt forms of squalamine dilactate
Application: 60/674,531 →
Polymorphic and Amorphous Salt Forms of Squalamine Dilactate
Patent: 7,981,876 →
Application: 11/410,098 →
Publication: US 2007/0010504
Polymorphic and Amorphous Salt Forms of Squalamine Dilactate
Patent: 8,716,270 →
Application: 13/166,911 →
Publication: US 2012/0022035
Related Assignments (7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 19, 2006
From: CHELLQUIST, ERIC; DOUBLEDAY, MARY; GILBERT, CHARLES; ZHANG, XUEHAI
To: GENAERA CORPORATION
Reel/Frame 018283/0136 →
Assignment of Assignor's Interest May 9, 2011
From: GENAERA LIQUIDATING TRUST
To: OHR PHARMACEUTICAL, INC.
Reel/Frame 026246/0796 →
Liquidating Trust Agreement Mar 16, 2012
From: GENAERA CORPORATION
To: ARGYCE LLC
Reel/Frame 027874/0365 →
Assignment of Assignor's Interest Jan 28, 2015
From: CHELLQUIST, ERIC; DOUBLEDAY, MARY; GILBERT, CHARLES; ZHANG, XUEHAI
To: GENAERA CORPORATION
Reel/Frame 034836/0672 →
Assignment of Assignor's Interest Jan 28, 2015
From: GENAERA LIQUIDATING TRUST
To: OHR PHARMACEUTICAL, INC.
Reel/Frame 034836/0690 →
Liquidating Trust Agreement Jan 28, 2015
From: GENAERA CORPORATION
To: ARGYCE LLC
Reel/Frame 034838/0844 →
Certificate of Change of the Company's Address Mar 22, 2016
From: OHR PHARMACEUTICAL, INC.
To: OHR PHARMACEUTICAL, INC.
Reel/Frame 038215/0748 →